Mediation of the total effect of cystic fibrosis‐related diabetes on mortality: A <scp>UK</scp> Cystic Fibrosis Registry cohort study-Reference-Cited by-同舟云学术

Mediation of the total effect of cystic fibrosis‐related diabetes on mortality: A UK Cystic Fibrosis Registry cohort study

Published:2022-09-16 Issue:11 Volume:39 Page:
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet Med

Author:

Tanner Kamaryn T.¹^ORCID,Daniel Rhian M.²^ORCID,Bilton Diana³⁴^ORCID,Simmonds Nicholas J.³⁴,Sharples Linda D.¹^ORCID,Keogh Ruth H.¹^ORCID

Affiliation:

1. Department of Medical Statistics The London School of Hygiene and Tropical Medicine London UK

2. Division of Population Medicine Cardiff University Cardiff UK

3. Imperial College London, Faculty of Medicine National Heart and Lung Institute London UK

4. Royal Brompton Hospital London UK

Funder

UK Research and Innovation

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dme.14958

Reference29 articles.

1. Cystic Fibrosis–Related Diabetes: Current Trends in Prevalence, Incidence, and Mortality

2. National Institute for Health and Care Excellence (NICE).Cystic fibrosis: diagnosis and management. NICE guideline [NG78]. Published2017. Accessed June 7 2021.https://www.nice.org.uk/guidance/ng78/chapter/Recommendations#annual‐and‐routine‐reviews

4. ISPAD Clinical Practice Consensus Guidelines 2018: Management of cystic fibrosis-related diabetes in children and adolescents

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What the future holds: cystic fibrosis and aging;Frontiers in Medicine;2024-01-08

2. Continuous Glucose Monitoring as an Additional Tool in Early Cystic Fibrosis-Related Diabetes Monitoring and in Evaluation of Short-Term Sitagliptin Response;Biomedicines;2023-06-19